Experiences and expectations for glioma immunotherapeutic approaches

Bibliographic Details
Main Authors: Ryuya eYamanaka, Azusa eHayano
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00355/full
id doaj-291cfe3935e046ad9af7ea40a58724b5
record_format Article
spelling doaj-291cfe3935e046ad9af7ea40a58724b52020-11-25T01:00:37ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2014-12-01410.3389/fonc.2014.00355120866Experiences and expectations for glioma immunotherapeutic approachesRyuya eYamanaka0Azusa eHayano1Kyoto Prefectural University of MedicineKyoto Prefectural University of Medicinehttp://journal.frontiersin.org/Journal/10.3389/fonc.2014.00355/fullCentral Nervous SystemGliomaImmunotherapydendritic cellpeptidePD-1
collection DOAJ
language English
format Article
sources DOAJ
author Ryuya eYamanaka
Azusa eHayano
spellingShingle Ryuya eYamanaka
Azusa eHayano
Experiences and expectations for glioma immunotherapeutic approaches
Frontiers in Oncology
Central Nervous System
Glioma
Immunotherapy
dendritic cell
peptide
PD-1
author_facet Ryuya eYamanaka
Azusa eHayano
author_sort Ryuya eYamanaka
title Experiences and expectations for glioma immunotherapeutic approaches
title_short Experiences and expectations for glioma immunotherapeutic approaches
title_full Experiences and expectations for glioma immunotherapeutic approaches
title_fullStr Experiences and expectations for glioma immunotherapeutic approaches
title_full_unstemmed Experiences and expectations for glioma immunotherapeutic approaches
title_sort experiences and expectations for glioma immunotherapeutic approaches
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2014-12-01
topic Central Nervous System
Glioma
Immunotherapy
dendritic cell
peptide
PD-1
url http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00355/full
work_keys_str_mv AT ryuyaeyamanaka experiencesandexpectationsforgliomaimmunotherapeuticapproaches
AT azusaehayano experiencesandexpectationsforgliomaimmunotherapeuticapproaches
_version_ 1725212833804713984